Endothelial cell surface F1-F0 ATP synthase (Ecto-ATP synthase)

Endothelial cell surface F1-F0 ATP synthase, often referred to as ecto-ATP synthase, is a multi-subunit enzyme complex located on the external plasma membrane of vascular endothelial cells [1, 9]. While structurally identical to the mitochondrial ATP synthase, this ectopic form functions in the extracellular environment to synthesize and hydrolyze ATP, thereby regulating local concentrations of purine nucleotides and the extracellular pH [1, 6]. It acts as a high-affinity receptor for angiostatin, a potent endogenous inhibitor of angiogenesis, and its activity is essential for endothelial cell migration, proliferation, and tube formation [2, 4]. In oncology, targeting this enzyme is a strategic approach to inhibit tumor-associated neovascularization, as its blockade triggers a caspase-dependent apoptotic pathway specifically in endothelial cells [11]. Beyond cancer, it is implicated in cardiovascular diseases like atherosclerosis and hypertension through its interactions with apolipoprotein A-I and its role in modulating nitric oxide bioactivity [6, 13]. Therapeutic development focuses on small molecules, peptides like angiostatin, and monoclonal antibodies, though ensuring selectivity for the cell surface form over the vital mitochondrial pool remains a significant safety challenge [7, 10].

Other names

Ecto-F1-F0 ATP synthaseEctopic ATP synthaseCell surface ATP synthaseAngiostatin receptorEcto-ATPaseEcto-F1-ATPase

Inhibition of the catalytic activity (ATP synthesis and hydrolysis) of the cell surface ATP synthase complex, which disrupts extracellular purinergic signaling and triggers caspase-8, -9, and -3 mediated apoptosis in endothelial cells.